Improving vaccines for tuberculosis
Advancing Vaccine adjuvant Research for Tuberculosis (TB)
This study is working on creating better vaccines for tuberculosis, especially for people at higher risk like those with HIV, by testing different ingredients that help boost the vaccine's effectiveness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Sydney NIH-funded |
| Lab location | 1 site (Sydney, Australia) |
| Project ID | NIH-11196785 on NIH RePORTER |
What this research studies
This research focuses on developing better vaccines for tuberculosis (TB), particularly for individuals at higher risk, such as those living with HIV. The team will compare different vaccine adjuvants—substances that enhance the body's immune response to the vaccine—alongside TB antigens to identify the most effective combinations. Using mouse models, they will evaluate these combinations before testing the best candidates in non-human primates. The ultimate goal is to create vaccines that can prevent TB infection and improve treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for tuberculosis, particularly those living with HIV.
Not a fit: Patients who are not at risk for tuberculosis or those who have already been vaccinated with existing TB vaccines may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that significantly reduce the incidence of tuberculosis, especially in vulnerable populations.
How similar studies have performed: Previous research has shown promise in enhancing vaccine efficacy through the use of adjuvants, indicating that this approach could lead to significant advancements in TB vaccine development.
Where this research is happening
Sydney, Australia
- University of Sydney — Sydney, Australia (Active)
Researchers
- Principal investigator: Britton, Warwick — University of Sydney
- Study coordinator: Britton, Warwick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.